Adaptive Biotechnologies Corporation (ADPT) vs Mirum Pharmaceuticals, Inc. (MIRM)
A side-by-side comparison of Adaptive Biotechnologies Corporation and Mirum Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADPT
Adaptive Biotechnologies Corporation
$27.59HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
MIRM
Mirum Pharmaceuticals, Inc.
$79.47HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ADPT vs MIRM
growth of $100 · dividends reinvested · last 7yADPT -21.5% (-3.4%/yr)MIRM +516.4% (+29.7%/yr)MIRM compounded faster over this window
Log scale — wide-divergence pair
ADPT MIRM
ADPT vs MIRM: by the numbers
- •MIRM is the larger company ($4.85B vs $4.41B market cap).
- •Both run net losses; ADPT's is the smaller (-20.73% vs -139.18% net margin).
- •MIRM grew revenue faster over the past five years (123.86% vs 18.22% CAGR).
Metrics side by side
Valuation
| Metric | ADPT | MIRM |
|---|---|---|
| P/S ratio | 14.33 | 7.84 |
| P/B ratio | 30.89 | N/A |
Profitability
| Metric | ADPT | MIRM |
|---|---|---|
| Gross margin | 75.44% | 81.70% |
| Operating margin | -20.62% | -4.25% |
| Net margin | -20.73% | -139.18% |
| ROE | -44.68% | N/A |
| ROIC | -6.67% | -13.09% |
Growth (annualized)
| Metric | ADPT | MIRM |
|---|---|---|
| Revenue CAGR (5Y) | 18.22% | 123.86% |
| Total return CAGR (5Y) | -1.77% | 37.24% |
Frequently asked
- Which has grown faster, ADPT or MIRM?
- Over the past five years, MIRM grew revenue faster — ADPT at a 18.22% CAGR versus MIRM at 123.86%.
- How have ADPT and MIRM total returns compared?
- Over the past 5 years, ADPT delivered -1.77% and MIRM delivered 37.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Adaptive Biotechnologies ROEMirum Pharmaceuticals ROEAdaptive Biotechnologies operating marginMirum Pharmaceuticals operating marginAdaptive Biotechnologies revenue growthMirum Pharmaceuticals revenue growthAdaptive Biotechnologies free cash flowMirum Pharmaceuticals free cash flow
Adaptive Biotechnologies & Mirum Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.